US AIDS Conference
SAN FRANCISCO--(BUSINESS WIRE)--Data presented today from a 310 patient, 52 week, double-blind, controlled clinical trial demonstrates that a micronutrient supplement, Replenish+™ delays the progression of AIDS in HIV-infected patients not receiving antiretroviral treatment (ART).1
Replenish+™ formulated by study investigator Dr Harold Foster, delayed the progression of HIV to AIDS as observed by significant increases in CD4 counts, glutathione peroxidase levels, weight and quality of life parameters (as measured by Karnofsky scores).